Physician profile
Billy E Roberts
NPI 1962674176
$751.30
in general payments reported to CMS, 2019-2025
15 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $115 · 2023: $172 · 2024: $157 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $135.94 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $79.66 | 2023 | Verquvo |
| Inspire Medical Systems, INC. | $79.17 | 2025 | Inspire |
| Philips North America LLC | $76.84 | 2024-2025 | (Ck4) Mcot, (5091) Amb Mon & Diag Und, Extended Holter |
| Astrazeneca Pharmaceuticals LP | $58.50 | 2021-2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $51.35 | 2021-2023 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $48.36 | 2025 | |
| Medtronic, INC. | $40.21 | 2023-2024 | Linq II |
| Shockwave Medical, INC | $36.17 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Pfizer INC. | $35.61 | 2023-2024 | |
| Abbott Laboratories | $33.73 | 2022 | |
| Esperion Therapeutics, INC. | $23.59 | 2025 | Nexletol |
| Boston Scientific Corporation | $21.68 | 2025 | Watchman Access System |
| Laborie Medical Technologies Corp. | $15.54 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Billy Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.